Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial. (2021)

First Author: Hochberg MC
Attributed to:  Advanced Pain Discovery Platform (APDP) Programme Director funded by SPF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/art.41674

PubMed Identifier: 33538113

Publication URI: http://europepmc.org/abstract/MED/33538113

Type: Journal Article/Review

Volume: 73

Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)

Issue: 7

ISSN: 2326-5191